John Orland Schorge MD
General Obstetrics, Gynecologic Oncology, Minimally Invasive / Endoscopic Surgery
Professor and Chair - University of Tennessee Health Science Center
Join to View Full Profile
880 Madison AveMemphis, TN 38103
Phone+1 901-515-3500
Fax+1 901-515-3509
Dr. Schorge is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Schorge is an obstetrician and gynecologist based in Memphis, TN, specializing in general obstetrics, gynecologic oncology, and minimally invasive/endoscopic surgery. He completed his fellowship in gynecologic oncology in 2000 and residency in obstetrics and gynecology in 1997 at Mass General Brigham/Brigham and Women's Hospital. He graduated from Vanderbilt University School of Medicine in 1993. Dr. Schorge has authored multiple publications, including guidelines and studies on ovarian, cervical, and vulvar cancers, which have been cited numerous times by other research. His work is recognized by CMS Meaningful Use Stage 1 and 2 Certifications through various Epic Systems Corporations and the Partners Healthcare System.
Education & Training
Mass General Brigham/Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2000- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 1993 - 1997
Vanderbilt University School of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 2022 - 2026
MA State Medical License 1997 - 2022
NH State Medical License 2008 - 2022
TX State Medical License 2000 - 2011
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 7 citationsResults of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ova...Jubilee Brown, Austin Miller, Laura L Holman, Floor Backes, Christa Nagel
Gynecologic Oncology. 2024-11-01 - 88 citationsNCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01 - 64 citationsVulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.Nadeem R Abu-Rustum, Catheryn M Yashar, Rebecca Arend, Emma Barber, Kristin Bradley
Journal of the National Comprehensive Cancer Network. 2024-03-01
Other
- Cervical adenocarcinoma in situSchorge JO, Carmen MG
http://www.uptodate.com/contents/cervical-adenocarcinoma-in-situ
UpToDate, Wolters Kluwer Health - 2012-12-07 - Invasive cervical adenocarcinomaSchorge JO, Carmen MG
http://www.uptodate.com/contents/invasive-cervical-adenocarcinoma
UpToDate, Wolters Kluwer Health - 2013-02-26
Press Mentions
Updated Recommendations on BRCA-Related Cancer ScreeningSeptember 25th, 2019
Ovarian Cancer Survivors CourseFebruary 12th, 2016
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
